These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25003936)

  • 1. Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications.
    Tambascia MA; Malerbi DA; Eliaschewitz FG
    Einstein (Sao Paulo); 2014 Apr; 12(2):251-3. PubMed ID: 25003936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
    Nicolaus M; Brödl J; Linke R; Woerle HJ; Göke B; Schirra J
    J Clin Endocrinol Metab; 2011 Jan; 96(1):229-36. PubMed ID: 21047924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of starvation and short-term refeeding on gastric emptying and postprandial blood glucose regulation in adolescent girls with anorexia nervosa.
    Heruc GA; Little TJ; Kohn MR; Madden S; Clarke SD; Horowitz M; Feinle-Bisset C
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E565-E573. PubMed ID: 29969316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
    Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of gastric emptying in diabetes.
    Phillips LK; Rayner CK; Jones KL; Horowitz M
    J Diabetes Complications; 2014; 28(6):894-903. PubMed ID: 25047170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide can reduce glucose independent of islet hormones or gastric emptying.
    Ionut V; Zheng D; Stefanovski D; Bergman RN
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E269-77. PubMed ID: 18492781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis related diabetes--a new perspective on the optimal management of postprandial glycemia.
    Perano S; Rayner CK; Couper J; Martin J; Horowitz M
    J Diabetes Complications; 2014; 28(6):904-11. PubMed ID: 25060530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia.
    Khoo J; Rayner CK; Feinle-Bisset C; Jones KL; Horowitz M
    Neurogastroenterol Motil; 2010 Dec; 22(12):1270-8. PubMed ID: 20939851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric Emptying Is More Rapid in Adolescents With Type 1 Diabetes and Impacts on Postprandial Glycemia.
    Perano SJ; Rayner CK; Kritas S; Horowitz M; Donaghue K; Mpundu-Kaambwa C; Giles L; Couper JJ
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2248-53. PubMed ID: 25871840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.
    Chowdhury S; Reeds DN; Crimmins DL; Patterson BW; Laciny E; Wang S; Tran HD; Griest TA; Rometo DA; Dunai J; Wallendorf MJ; Ladenson JH; Polonsky KS; Wice BM
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G301-9. PubMed ID: 24356886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic gastroparesis and its impact on glycemia.
    Chang J; Rayner CK; Jones KL; Horowitz M
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):745-62. PubMed ID: 21095542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.
    Wu T; Little TJ; Bound MJ; Borg M; Zhang X; Deacon CF; Horowitz M; Jones KL; Rayner CK
    Diabetes Care; 2016 Apr; 39(4):511-7. PubMed ID: 26786576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
    Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional Relationship between Gastric Emptying and Plasma Glucose Control in Normoglycemic Individuals and Diabetic Patients.
    Mihai BM; Mihai C; Cijevschi-Prelipcean C; Grigorescu ED; Dranga M; Drug V; Sporea I; Lăcătușu CM
    J Diabetes Res; 2018; 2018():1736959. PubMed ID: 30402500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.
    Wu T; Bound MJ; Zhao BR; Standfield SD; Bellon M; Jones KL; Horowitz M; Rayner CK
    Diabetes Care; 2013 Jul; 36(7):1913-8. PubMed ID: 23359361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.
    Perano SJ; Couper JJ; Horowitz M; Martin AJ; Kritas S; Sullivan T; Rayner CK
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2486-93. PubMed ID: 24670086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
    Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
    J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
    Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G413-9. PubMed ID: 23275610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
    Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M
    J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.